RNA hacking, which we developed, is an innovative technology that artificially alters the three-dimensional structure of target mRNA to control protein translation. This mechanism can form the basis of next-generation therapies that overcome the challenges faced by existing nucleic acid drugs. By selectively controlling the function of target genes while suppressing side effects, this technology is expected to offer a new approach to diseases that have been difficult to treat.